|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBSCO_on1184666447 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
200818t20202020enkab ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d N$T
|d EBLCP
|d UKAHL
|d OCLCO
|d UKMGB
|d OCLCF
|d OCLCA
|d OCLCO
|d OCLCQ
|d STF
|
015 |
|
|
|a GBC0C9720
|2 bnb
|
016 |
7 |
|
|a 019788558
|2 Uk
|
019 |
|
|
|a 1153767993
|a 1390415811
|
020 |
|
|
|a 9781527549944
|q (electronic bk.)
|
020 |
|
|
|a 1527549941
|q (electronic bk.)
|
020 |
|
|
|z 9781527548695
|
020 |
|
|
|z 1527548694
|
029 |
1 |
|
|a UKMGB
|b 019788558
|
035 |
|
|
|a (OCoLC)1184666447
|z (OCoLC)1153767993
|z (OCoLC)1390415811
|
037 |
|
|
|a 9781527549944
|b Cambridge Scholars Publishing
|
043 |
|
|
|a f-sg---
|
050 |
|
4 |
|a QR189.5.M4
|b G37 2020
|
060 |
|
4 |
|a WC 11 HS1
|
082 |
0 |
4 |
|a 614.5/2309663
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Garenne, Michel,
|e author.
|
245 |
1 |
4 |
|a The Niakhar high-titer measles vaccine trial, 1987-1990 /
|c by Michel Garenne, in collaboration with Odile Leroy, Jean-Pierre Beau, Ibra Séne, Hilton Whittle, Abdourahmane Sow.
|
264 |
|
1 |
|a Newcastle upon Tyne, UK :
|b Cambridge Scholars Publishing,
|c 2020.
|
264 |
|
4 |
|c ©2020
|
300 |
|
|
|a 1 online resource (xix, 305 pages ):
|b illustrations, map.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|2 rdamedia
|
338 |
|
|
|a online resource
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
588 |
|
|
|a Description based on print version record.
|
520 |
|
|
|a This study reports the methodology and findings of a randomized controlled vaccine trial conducted in Senegal in 1987-1990. Two high-titer measles vaccines of different strains (Edmonston-Zagreb and Schwarz) were compared with a standard vaccine (the Schwarz strain) among infants aged 5 to 10 months. Comparison focused on clinical efficacy, immunogenicity and safety. Although both high-titer vaccines induced an immunogenic response even when given at the age of 5 months, they induced a lower level of antibodies, had more vaccine failures, and were not safe, inducing an excess mortality within.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Measles vaccine
|x History.
|
650 |
|
0 |
|a Vaccination
|z Senegal
|x History
|y 20th century.
|
650 |
|
0 |
|a Vaccination
|x Complications
|z Senegal
|x History
|y 20th century.
|
650 |
|
0 |
|a Clinical trials
|z Senegal
|x History
|y 20th century.
|
650 |
|
2 |
|a Measles Vaccine
|x history
|
651 |
|
2 |
|a Senegal
|
650 |
|
6 |
|a Vaccin antimorbilleux
|x Histoire.
|
650 |
|
6 |
|a Vaccination
|z Sénégal
|x Histoire
|y 20e siècle.
|
650 |
|
6 |
|a Vaccination
|x Complications et séquelles
|z Sénégal
|x Histoire
|y 20e siècle.
|
650 |
|
6 |
|a Études cliniques
|z Sénégal
|x Histoire
|y 20e siècle.
|
650 |
|
7 |
|a Clinical trials
|2 fast
|0 (OCoLC)fst00864429
|
650 |
|
7 |
|a Measles vaccine
|2 fast
|0 (OCoLC)fst01013172
|
650 |
|
7 |
|a Vaccination
|2 fast
|0 (OCoLC)fst01163544
|
650 |
|
7 |
|a Vaccination
|x Complications
|2 fast
|0 (OCoLC)fst01163545
|
651 |
|
7 |
|a Senegal
|2 fast
|0 (OCoLC)fst01204328
|
648 |
|
7 |
|a 1900-1999
|2 fast
|
655 |
|
7 |
|a History
|2 fast
|0 (OCoLC)fst01411628
|
700 |
1 |
|
|a Leroy, Odile,
|e contributor.
|
700 |
1 |
|
|a Beau, Jean--Pierre,
|e contributor.
|
700 |
1 |
|
|a Séne, Ibra,
|e contributor.
|
776 |
0 |
8 |
|i Print version:
|z 9781527548695
|z 1527548694
|w (OCoLC)1180219619
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2464930
|z Texto completo
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 16761263
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 2464930
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH37415713
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6191295
|
994 |
|
|
|a 92
|b IZTAP
|